申请人:Barsanti A. Paul
公开号:US20050069555A1
公开(公告)日:2005-03-31
The present invention is directed to novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, novel methods for treating viral infections, including HCV, by administering the compounds, and novel methods for modulating an immune response by administering the compounds.
本发明涉及新型免疫增强剂、新型疫苗佐剂、新型化合物和药物组合物、通过给予该化合物治疗包括HCV在内的病毒感染的新方法,以及通过给予该化合物调节免疫反应的新方法。